Literature DB >> 12069531

The role of endothelial cell-derived inflammatory and vasoactive mediators in the pathogenesis of bluetongue.

Christopher D DeMaula1, Christian M Leutenegger, Kyle R Bonneau, N James MacLachlan.   

Abstract

Bluetongue is an insect-transmitted disease of sheep and wild ruminants that is caused by bluetongue virus (BTV). Cattle are asymptomatic reservoir hosts of BTV. Infection of lung microvascular endothelial cells (ECs) is central to the pathogenesis of BTV infection of both sheep and cattle, but it is uncertain as to why sheep are highly susceptible to BTV-induced microvascular injury, whereas cattle are not. Thus, to better characterize the pathogenesis of bluetongue, the transcription of genes encoding a variety of vasoactive and inflammatory mediators was quantitated in primary ovine lung microvascular ECs (OLmVECs) exposed to BTV and/or inflammatory mediators. BTV infection of OLmVECs increased the transcription of genes encoding interleukin- (IL) 1 and IL-8, but less so IL-6, cyclooxygenase-2, and inducible nitric oxide synthase. In contrast, we previously have shown that transcription of genes encoding all of these same mediators is markedly increased in BTV-infected bovine lung microvascular ECs and that BTV-infected bovine ECs produce substantially greater quantities of prostacyclin than do sheep ECs. Thus, sheep and cattle were experimentally infected with BTV to further investigate the role of EC-derived vasoactive mediators in the pathogenesis of bluetongue. The ratio of thromboxane to prostacyclin increased during BTV infection of both sheep and cattle, but was significantly greater in sheep (P = 0.001). Increases in the ratio of thromboxane to prostacyclin, indicative of enhanced coagulation, coincided with the occurrence of clinical manifestations of bluetongue in BTV-infected sheep. The data suggest that inherent species-specific differences in the production and activities of EC-derived mediators contribute to the sensitivity of sheep to BTV-induced microvascular injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069531     DOI: 10.1006/viro.2002.1476

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Bluetongue virus infection activates bovine monocyte-derived macrophages and pulmonary artery endothelial cells.

Authors:  Clifton P Drew; Meera C Heller; Christie Mayo; Joie L Watson; N James Maclachlan
Journal:  Vet Immunol Immunopathol       Date:  2010-03-10       Impact factor: 2.046

2.  Bluetongue virus infection alters the impedance of monolayers of bovine endothelial cells as a result of cell death.

Authors:  Clifton P Drew; Ian A Gardner; Christie E Mayo; Eiko Matsuo; Polly Roy; N James MacLachlan
Journal:  Vet Immunol Immunopathol       Date:  2010-03-10       Impact factor: 2.046

3.  Novel Function of Bluetongue Virus NS3 Protein in Regulation of the MAPK/ERK Signaling Pathway.

Authors:  Damien Vitour; Grégory Caignard; Cindy Kundlacz; Marie Pourcelot; Aurore Fablet; Rayane Amaral Da Silva Moraes; Thibaut Léger; Bastien Morlet; Cyril Viarouge; Corinne Sailleau; Mathilde Turpaud; Axel Gorlier; Emmanuel Breard; Sylvie Lecollinet; Piet A van Rijn; Stephan Zientara
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

4.  Sensing and control of bluetongue virus infection in epithelial cells via RIG-I and MDA5 helicases.

Authors:  Emilie Chauveau; Virginie Doceul; Estelle Lara; Micheline Adam; Emmanuel Breard; Corinne Sailleau; Cyril Viarouge; Alexandra Desprat; Gilles Meyer; Isabelle Schwartz-Cornil; Suzana Ruscanu; Bernard Charley; Stéphan Zientara; Damien Vitour
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

5.  Bluetongue virus targets conventional dendritic cells in skin lymph.

Authors:  Behzad Hemati; Vanessa Contreras; Céline Urien; Michel Bonneau; Haru-Hisa Takamatsu; Peter P C Mertens; Emmanuel Bréard; Corinne Sailleau; Stéphan Zientara; Isabelle Schwartz-Cornil
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

6.  Involvement of the skin during bluetongue virus infection and replication in the ruminant host.

Authors:  Karin E Darpel; Paul Monaghan; Jennifer Simpson; Simon J Anthony; Eva Veronesi; Harriet W Brooks; Heather Elliott; Joe Brownlie; Haru-Hisa Takamatsu; Philip S Mellor; Peter Pc Mertens
Journal:  Vet Res       Date:  2012-04-30       Impact factor: 3.683

7.  Role of cellular caspases, nuclear factor-kappa B and interferon regulatory factors in Bluetongue virus infection and cell fate.

Authors:  Meredith E Stewart; Polly Roy
Journal:  Virol J       Date:  2010-12-06       Impact factor: 4.099

8.  Pathological Characterization Of IFNAR(-/-) Mice Infected With Bluetongue Virus Serotype 4.

Authors:  Alejandro Marín-López; Roberto Bermúdez; Eva Calvo-Pinilla; Sandra Moreno; Alejandro Brun; Javier Ortego
Journal:  Int J Biol Sci       Date:  2016-11-24       Impact factor: 6.580

9.  Infection kinetics and antibody responses in Deccani sheep during experimental infection and superinfection with bluetongue virus serotypes 4 and 16.

Authors:  Kalyani Putty; Abdul Muzeer Shaik; Shaik Jahangeer Peera; Y Narasimha Reddy; P P Rao; Sunil R Patil; M Shreekanth Reddy; B Susmitha; J Shiva Jyothi
Journal:  Vet World       Date:  2019-01-07

10.  Assessment of cross-protection induced by a bluetongue virus (BTV) serotype 8 vaccine towards other BTV serotypes in experimental conditions.

Authors:  Ludovic Martinelle; Fabiana Dal Pozzo; Christine Thys; Ilse De Leeuw; Willem Van Campe; Kris De Clercq; Etienne Thiry; Claude Saegerman
Journal:  Vet Res       Date:  2018-07-16       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.